Aytu BioPharma, Inc.
Aytu BioPharma, Inc., a prominent player in the biopharmaceutical industry, is headquartered in the United States. Founded in 2014, the company has rapidly established itself in the development and commercialisation of innovative therapeutics, particularly in the fields of urology and men's health. Aytu's core products, including the well-regarded prescription medications and diagnostic solutions, are designed to address unmet medical needs, setting them apart in a competitive market. With a focus on enhancing patient outcomes, Aytu BioPharma has achieved significant milestones, including strategic partnerships and product launches that underscore its commitment to advancing healthcare. The company’s unique approach to drug development and its dedication to quality have positioned it as a notable entity within the biopharmaceutical landscape, making strides in improving the lives of patients across its operational regions.
DitchCarbon Score
How does Aytu BioPharma, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Aytu BioPharma, Inc.'s score of 25 is lower than 70% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Aytu BioPharma, Inc.'s reported carbon emissions
Aytu BioPharma, Inc., headquartered in the US, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Furthermore, the company has not established any documented reduction targets or commitments to climate initiatives, such as those outlined by the Science Based Targets initiative (SBTi). As there are no emissions data or reduction initiatives available, Aytu BioPharma's climate commitments remain unclear. The company does not appear to inherit any emissions data from a parent or related organisation, indicating that it operates independently in this regard. In the context of the pharmaceutical industry, where sustainability and climate action are increasingly important, Aytu BioPharma may need to consider developing a comprehensive strategy to address carbon emissions and set measurable targets to align with industry standards.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Aytu BioPharma, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
